Consistently, in prostate cancer cells, TGF-β- and epidermal growth factor (EGF)-induced EMT phenotypes were found to be associated with downregulation of human leukocyte antigen (HLA)-I [72]. The gene discussed is EGF; the disease is prostate carcinoma.